Primary |
Drug Detoxification |
22.2% |
Overdose |
19.4% |
Detoxification |
11.1% |
General Anaesthesia |
8.3% |
Pain |
5.6% |
Toxicity To Various Agents |
5.6% |
Antiemetic Supportive Care |
2.8% |
Back Pain |
2.8% |
Depressed Level Of Consciousness |
2.8% |
Diarrhoea |
2.8% |
Drug Withdrawal Maintenance Therapy |
2.8% |
Hypotension |
2.8% |
Mental Status Changes |
2.8% |
Reversal Of Opiate Activity |
2.8% |
Sedation |
2.8% |
Somnolence |
2.8% |
|
Tremor |
12.5% |
Ventricular Fibrillation |
12.5% |
Pulseless Electrical Activity |
8.3% |
Adverse Drug Reaction |
4.2% |
Agitation |
4.2% |
C-reactive Protein Increased |
4.2% |
Convulsion |
4.2% |
Gastroenteritis |
4.2% |
Hypertension |
4.2% |
Muscle Twitching |
4.2% |
Neuroleptic Malignant Syndrome |
4.2% |
Respiratory Distress |
4.2% |
Respiratory Rate Decreased |
4.2% |
Sepsis |
4.2% |
Somnolence |
4.2% |
Unevaluable Event |
4.2% |
Vaginal Haemorrhage |
4.2% |
Visual Disturbance |
4.2% |
Vomiting |
4.2% |
|
Secondary |
Product Used For Unknown Indication |
38.0% |
Drug Abuse |
24.1% |
Drug Use For Unknown Indication |
9.8% |
Drug Detoxification |
5.0% |
Drug Exposure During Pregnancy |
3.4% |
Anaesthesia |
3.1% |
Pain |
2.9% |
Drug Dependence |
2.3% |
Hypotension |
1.2% |
Cancer Pain |
1.1% |
Spinal Anaesthesia |
1.1% |
Overdose |
1.0% |
Constipation |
0.9% |
General Anaesthesia |
0.9% |
Agitation |
0.8% |
Back Pain |
0.8% |
Depression |
0.8% |
Drug Level |
0.8% |
Drug Withdrawal Maintenance Therapy |
0.8% |
Hypertension |
0.8% |
|
Vomiting |
11.4% |
Sleep Disorder |
8.0% |
Drug Withdrawal Syndrome Neonatal |
6.8% |
Death |
5.7% |
Toxicity To Various Agents |
5.7% |
Troponin Increased |
5.7% |
Ventricular Tachycardia |
5.7% |
Pulseless Electrical Activity |
4.5% |
Respiratory Distress |
4.5% |
Tachycardia |
4.5% |
Torticollis |
4.5% |
Unresponsive To Stimuli |
4.5% |
Ventricular Fibrillation |
4.5% |
Accidental Overdose |
3.4% |
Atrial Fibrillation |
3.4% |
Delayed Recovery From Anaesthesia |
3.4% |
Diarrhoea |
3.4% |
Medication Error |
3.4% |
Pulmonary Artery Stenosis |
3.4% |
Urinary Retention |
3.4% |
|
Concomitant |
Product Used For Unknown Indication |
40.1% |
Drug Use For Unknown Indication |
15.2% |
Pain |
10.6% |
Surgery |
5.1% |
Nausea |
4.4% |
Hypertension |
3.7% |
Prophylaxis |
2.6% |
Abdominal Pain |
2.2% |
Constipation |
2.1% |
Multiple Myeloma |
2.0% |
Medical Diet |
1.8% |
Prophylaxis Against Transplant Rejection |
1.4% |
Non-small Cell Lung Cancer |
1.3% |
Oesophagitis |
1.3% |
Depression |
1.3% |
Vomiting |
1.1% |
Acute Lymphocytic Leukaemia |
1.0% |
Pruritus |
1.0% |
Rheumatoid Arthritis |
1.0% |
Breast Cancer |
0.9% |
|
Somnolence |
10.7% |
Weight Decreased |
10.0% |
Vomiting |
9.3% |
Wrist Fracture |
6.7% |
Renal Failure |
6.0% |
Sepsis |
6.0% |
Thrombocytopenia |
4.7% |
Pulmonary Embolism |
4.0% |
Unresponsive To Stimuli |
4.0% |
Venoocclusive Disease |
4.0% |
White Blood Cell Disorder |
4.0% |
Wound Infection |
4.0% |
Abdominal Pain |
3.3% |
Anaemia |
3.3% |
Drug Toxicity |
3.3% |
General Physical Health Deterioration |
3.3% |
Hypoxia |
3.3% |
Neutropenia |
3.3% |
Respiratory Distress |
3.3% |
Septic Shock |
3.3% |
|
Interacting |
Product Used For Unknown Indication |
33.3% |
Drug Dependence |
22.2% |
Anxiety |
11.1% |
Drug Level |
11.1% |
Neuralgia |
11.1% |
Pain |
11.1% |
|
Therapeutic Response Increased |
50.0% |
Respiratory Depression |
25.0% |
Rhabdomyolysis |
25.0% |
|